AVITA Medical, Inc. (RCEL)

AVITA Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jun 30, 2021
Cash & Equivalents	15.42	14.05	22.12	18.16	55.51	110.75
Short-Term Investments	7.89	21.84	66.94	61.18	29.65	-
Cash & Short-Term Investments	23.31	35.89	89.06	79.34	85.16	110.75
Cash Growth	-47.50%	-59.71%	12.24%	-6.83%	-23.10%	50.39%
Accounts Receivable	9.01	11.84	7.69	3.53	3.43	7.4
Other Receivables	0.03	0.12	0.23	1.18	0.09	0.48
Receivables	9.05	11.96	7.92	4.71	3.51	7.88
Inventory	7.24	7.27	5.6	2.13	2.13	1.65
Prepaid Expenses	1.77	1.88	1.43	0.92	1.12	0.85
Restricted Cash	-	-	-	-	0.2	0.2
Other Current Assets	-	-	-	0.36	0	-
Total Current Assets	41.37	57	104.01	87.46	92.13	121.33
Property, Plant & Equipment	13.01	13.59	4.32	2.05	2.81	2.94
Long-Term Investments	-	-	-	6.93	19.69	-
Other Intangible Assets	5.2	5.57	0.49	0.47	0.44	0.47
Long-Term Deferred Charges	-	-	-	-	0.5	0.61
Other Long-Term Assets	4.14	3.55	2.83	1.36	0.44	0.15
Total Assets	63.73	79.71	111.64	98.26	116.02	125.5
Accounts Payable	8.11	6.29	3.79	3	2.71	3.12
Accrued Expenses	6.13	12.55	8.14	6.7	5.36	3.32
Current Portion of Leases	-	0.9	0.9	0.61	0.72	0.7
Current Unearned Revenue	0.03	0.03	0.03	-	-	-
Other Current Liabilities	5.12	0.39	0.34	0.38	0.36	0.25
Total Current Liabilities	61.83	20.16	13.2	10.69	9.15	7.39
Long-Term Debt	-	42.25	39.81	-	-	-
Long-Term Leases	2.32	2.84	1.7	0.31	0.92	0.88
Long-Term Unearned Revenue	0.3	0.32	0.36	0.7	0.95	1.08
Other Long-Term Liabilities	5.94	9.65	7.51	1.83	0.38	0.5
Total Liabilities	70.39	75.21	62.58	13.52	11.39	9.85
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	392.78	367.57	350.04	339.83	332.48	328.89
Retained Earnings	-396.78	-359.81	-297.97	-262.59	-235.92	-221.5
Comprehensive Income & Other	-2.67	-3.26	-3.02	7.5	8.06	8.26
Shareholders' Equity	-6.67	4.5	49.06	84.74	104.62	115.66
Total Liabilities & Equity	63.73	79.71	111.64	98.26	116.02	125.5
Total Debt	44.77	45.99	42.41	0.92	1.64	1.58
Net Cash (Debt)	-21.46	-10.1	46.65	85.35	103.21	109.17
Net Cash Growth	-	-	-45.35%	-17.30%	-5.45%	53.35%
Net Cash Per Share	-0.80	-0.39	1.84	3.41	4.24	4.81
Filing Date Shares Outstanding	30.49	26.36	25.71	25.3	24.93	24.9
Total Common Shares Outstanding	30.49	26.35	25.68	25.21	24.93	24.9
Working Capital	-20.46	36.84	90.81	76.77	82.99	113.94
Book Value Per Share	-0.22	0.17	1.91	3.36	4.20	4.65
Tangible Book Value	-11.87	-1.07	48.57	84.28	104.18	115.18
Tangible Book Value Per Share	-0.39	-0.04	1.89	3.34	4.18	4.63
Machinery	6.43	6.2	3.02	1.97	1.88	1.81
Construction In Progress	0.81	0.44	0.09	0.26	0.03	0.05
Leasehold Improvements	4.87	4.61	0.37	0.26	0.24	0.24

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q